In terms of revenue, the global cell and gene therapy consumables market was estimated to be US$ 641.22 Mn in 2018 and is expected to reach US$ 6,999.35 Mn by 2027 growing at a CAGR of 30.43% over the forecast period. Some of the key market participants in the cell and gene therapy consumables market are Amgen Inc., ATLANTA BIOLOGICALS, bluebird bio, Inc., Cook Medical, Dendreon...